TrialFrontiers in immunology2023
Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis.
Yue Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it
TrialFrontiers in immunology2023
Yue Song et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.